Provided by Tiger Fintech (Singapore) Pte. Ltd.

SINO BIOPHARM

3.320
+0.0100.30%
Volume:82.32M
Turnover:272.59M
Market Cap:62.32B
PE:24.61
High:3.370
Open:3.340
Low:3.280
Close:3.310
Loading ...

BRIEF-Sino Biopharmaceutical Signs Exclusive Strategic Cooperation Agreement With Sciwind Biosciences

Reuters
·
27 Feb

Sino Biopharmaceutical - Signing of an Exclusive Strategic Cooperation Agreement With Sciwind Biosciences

THOMSON REUTERS
·
27 Feb

Sino Biopharmaceutical - Co, Sciwind Biosciences Established Exclusivity on Licensing and Cooperation in 19 Countries for Human Interleukin-29 Project

THOMSON REUTERS
·
27 Feb

Sino Biopharmaceutical Limited's (HKG:1177) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Simply Wall St.
·
11 Feb

Chinese Regulator Approves Sino Biopharmaceul's Tulobuterol Patches for Marketing

MT Newswires Live
·
07 Feb

Sino Biopharmaceutical's Anti-Inflammatory Medication Gets NMPA's Approval for Marketing

MT Newswires Live
·
07 Feb

Sino Biopharmaceutical - Tulobuterol Patches" Obtained Approval for Marketing From National Medical Products Administration of China

THOMSON REUTERS
·
07 Feb

Sino Biopharmaceutical - Approval for Marketing of "Loxoprofen Sodium Cataplasms" From China Nmpa

THOMSON REUTERS
·
07 Feb

Hong Kong stocks close firmer as Lunar New Year holiday kicks in

Reuters
·
28 Jan

Getting In Cheap On Sino Biopharmaceutical Limited (HKG:1177) Might Be Difficult

Simply Wall St.
·
14 Jan

Sino Biopharm Reports Positive Results in NSCLC Drug's Phase III Study

MT Newswires Live
·
27 Dec 2024

BRIEF-Sino Biopharmaceutical Says Positive Results From Phase III Study Of Benmelstobart Injection

Reuters
·
27 Dec 2024

Sino Biopharmaceutical - Benmelstobart Injection Primary Study Endpoint Progression-Free Survival Met

THOMSON REUTERS
·
27 Dec 2024

Sino Biopharm Cleared to Submit Marketing Application for New Indication of Tumor Drug

MT Newswires Live
·
19 Dec 2024

Sino Biopharmaceutical's Cancer Drug Shows Positive Results in Clinical Trials

MT Newswires Live
·
19 Dec 2024

Sino Biopharmaceutical - Permission Obtained to Submit Marketing Application for Indication of Benmelstobart Injection, Others From Nmpa

THOMSON REUTERS
·
19 Dec 2024